LobbyingAmerican Leprosy Missions lobbying by quarter
American Leprosy Missions's latest lobbying report covers Q2 2024, at under $5,000. Its first report covers Q3 2022; the issues it reports most are Health Issues.
American Leprosy Missions
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q3 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2022 | $20K | 1 |
| Q4 2022 | $20K | 1 |
| Q1 2023 | $20K | 1 |
| Q2 2023 | $20K | 1 |
| Q3 2023 | $20K | 1 |
| Q4 2023 | $20K | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Health issues6 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES6 reports
- SENATE6 reports
- U.S. Agency for International Development (USAID)6 reports
Firms it paid
| Firm | ||
|---|---|---|
| Merchant McIntyre & Associates | $120K | 8 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/07/24for Q2 2024 | Merchant McIntyre & Associates | Under $5,000 |
| 24/05/17for Q4 2023 | Merchant McIntyre & Associates | $20K |
| 24/04/22for Q1 2024 | Merchant McIntyre & Associates | Under $5,000 |
| 24/01/23for Q3 2023 | Merchant McIntyre & Associates | $20K |
| 23/07/15for Q2 2023 | Merchant McIntyre & Associates | $20K |
| 23/04/20for Q1 2023 | Merchant McIntyre & Associates | $20K |
| 23/01/22for Q4 2022 | Merchant McIntyre & Associates | $20K |
| 23/01/22for Q3 2022 | Merchant McIntyre & Associates | $20K |